Efficacy and safety of percutaneous life support during high-risk percutaneous coronary intervention, refractory cardiogenic shock and in-laboratory cardiopulmonary arrest

Journal of Invasive Cardiology

Volumn 23, Issue 4, 2011, Pages 141-147

  Bagai, Jayant ^a   Webb, David ^a   Kasasbeh, Ehab ^a   Crenshaw, Marshall ^a   Salloum, Joseph ^a   Chen, Jack ^b   Zhao, David ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHSIDE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CARDIOPULMONARY ARREST; CARDIOPULMONARY SUPPORT SYSTEM; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; HEART ASSIST DEVICE; HIGH RISK PATIENT; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS LEFT VENTRICULAR ASSIST DEVICE;

ADULT; ADVANCED CARDIAC LIFE SUPPORT; AGED; ANGIOPLASTY, BALLOON, CORONARY; COHORT STUDIES; CORONARY DISEASE; FEMALE; HEART ARREST; HEART-ASSIST DEVICES; HUMANS; LIFE SUPPORT CARE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SHOCK, CARDIOGENIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79955420159     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bergelson BA, Jacobs AK, Cupples LA, et al. Prediction of risk for hemodynamic compro-mise during percutaneous transluminal coronary angioplasty. Am J Cardiol 1992;70:1540-1545. (Pubitemid 23006065)
2. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-972.
3. Jensen LO, Kaltoft A, Thayssen P, et al. Outcome in high-risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention. Catheter Cardiovasc Interv 2010;75:101-108.
4. Vranckx P, Foley DP, de Feijter PJ, et al. Clinical introduction of the TandemHeart, a per-cutaneous left ventricular assist device, for circulatory support during high-risk percutaneous coronary intervention. Int J Cardiovasc Intervent 2003;5:35-39. (Pubitemid 36227313)
5. Aragon J, Lee MS, Kar S, Makkar RR. Percutaneous left ventricular assist device: "Tandem-Heart" for high-risk coronary intervention. Catheter Cardiovasc Interv 2005;65:346-352. (Pubitemid 40898176)
6. Kar B, Forrester M, Gemmato C, et al. Use of the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention J Invasive Cardiol 2006;18:A6.
7. Al-Husami W, Yturralde F, Mohanty G, et al. Single-center experience with the Tandem-Heart percutaneous ventricular assist device to support patients undergoing high-risk per-cutaneous coronary intervention. J Invasive Cardiol 2008;20:319-322. (Pubitemid 351940888)
8. Vranckx P, Meliga E, De Jaegere PP, et al. The TandemHeart percutaneous transseptal left ventricular assist device: A safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience. Euro Intervention 2008;4:331-337.
9. Vranckx P, Schultz CJ, Valgimigli M, et al. Assisted circulation using the TandemHeart(R) during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG Catheter Cardiovasc Interv 2009;74:311-312.
10. Windecker S. Percutaneous left ventricular assist devices for treatment of patients with car-diogenic shock. Curr Opin Crit Care 2007;13:521-527. (Pubitemid 47357452)
11. Bruckner BA, Jacob LP, Gregoric ID, et al. Clinical experience with the TandemHeart per-cutaneous ventricular assist device as a bridge to cardiac transplantation. Tex Heart Inst J 2008;35:447-450.
12. Gregoric ID, Jacob LP, La Francesca S, et al. The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge). Tex Heart Inst J 2008;35:125-129. (Pubitemid 351988639)
13. Prutkin JM, Strote JA, Stout KK. Percutaneous right ventricular assist device as support for cardiogenic shock due to right ventricular infarction. J Invasive Cardiol 2008;20:E215-E216.
14. Rajdev S, Irani A, Sharma S, Kni A Clinical utility of TandemHeart for high-risk tandem procedures: Percutaneous balloon aortic valvuloplasty followed by complex PCI. J Invasive Cardiol 2007;19:E346-E349. (Pubitemid 350071401)
15. Khalife WI, Kar B. The TandemHeart pVAD in the treatment of acute fulminant myocarditis. Tex Heart Inst J 2007;34:209-213. (Pubitemid 47066600)
16. Gregoric ID, Bieniarz MC, Arora H, et al. Percutaneous ventricular assist device support in a patient with a postinfarction ventricular septal defect. Tex Heart Inst J 2008;35:46-49. (Pubitemid 351581306)
17. Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock Eur Heart J 2005;26:1276-1283. (Pubitemid 41435457)
18. Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock A meta-analysis of controlled trials. Eur Heart J 2009;30:2102-2108.
19. Bagai J, Zhao D. Subcutaneous "figure-of-eight" stitch to achieve hemostasis after removal of large-caliber femoral venous sheaths. Cardiac Interventions Today August 2008: pp. 22-23.
20. Nashef SAM, Roques F, Michel P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9-13. (Pubitemid 29336425)
21. Sianos G, Morel M, Kappetein P, et al. The SYNTAX score: An angiographic tool grading the complexity of coronary artery disease. Eurointervention 2005;1:219-227.
22. Mehilli J, Kastrati A, Byrne RA, et al. Paclitaxel-versus sirolimus-eluting stents for unprotected left main coronary artery disease.J Am Coll Cardiol 2009;53:1760-1768.
23. Morice MC, Serruys PW, Kappetein AP, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the synergy between percutaneous coronary in-tervention with Taxus and cardiac surgery (SYNTAX) trial. Circulation 2010;121:2645-2653.
24. Bollati M, Gerasimou A, Sillano D, et al. Results of percutaneous drug-eluting stent implan-tation for unprotected left main coronary disease according to left ventricular systolic function Catheter Cardiovasc Interv 2010;75:586-593.
25. Capodanno D, Di Salvo ME, Tamburino C Impact of right coronary artery disease on mor-tality in patients undergoing percutaneous coronary intervention of unprotected left main coronary artery disease. Euro Intervention 2010;6:454-460.
26. Thiele H, Lauer B, Hambrecht R, et al. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 2001;104:2917-2922. (Pubitemid 33139103)
27. Burkhoff D, O'Neill W, Brunckhorst C, et al. Feasibility study of the use of the TandemHeart percutaneous ventricular assist device for treatment of cardiogenic shock Catheter Cardiovasc Interv 2006;68:211-217. (Pubitemid 44167670)
28. Bruckner BA, Jacob LP, Gregoric ID, et al. Clinical experience with the TandemHeart per-cutaneous ventricular assist device as a bridge to cardiac transplantation. Tex Heart Inst J 2008;35:447-450.
29. Gimelli G, Wolff MR Hemodynamically supported percutaneous coronary revascularization improves left ventricular function in patients with ischemic dilated cardiomyopathy at very high risk for surgery: A single-center experience. J Invasive Cardiol 2008;20:642-646.
30. Vogel RA The Maryland experience: Angioplasty and valvuloplasty using percutaneous car-diopulmonary support. Am J Cardiol 1988;62:K1 1-K14.
31. Tanaka K, Rangarajan K, Azarbal B, Tobis JM. Percutaneous ventricular assist during aortic valvuloplasty: Potential application to the deployment of aortic stent-valves. Tex Heart Inst J 2007;34:36-40. (Pubitemid 46588483)
32. Shawl FA, Domanski Ml, Wish MH, et al. Emergency cardiopulmonary bypass support in patients with cardiac arrest in the catheterization laboratory. Cathet Cardiovasc Diagn 1990;19:8-12. (Pubitemid 20082223)
33. Grambow DW, Deeb GM, Pavlides GS, et al. Emergent percutaneous cardiopulmonary by-pass in patients having cardiovascular collapse in th e cardiac catheterization laboratory. Am J Cardiol 1994; 73:872-875. (Pubitemid 24158307)
34. Thiagarajan RR, Brogan TV, Scheurer MA, et al. Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in adults. Ann Thorac Surg 2009;87:778-785.
35. Romagnoli E, Burzotta F, Trani C, et al. EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention. Heart 2009;95:43-48.
36. Dixon SR, Henriques JP, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): Initial US. experience. JACC Cardiovasc Interv 2009;2:91-96.